Confined or spread disease-Spread with distant metastasis Posts on Medivizor
Navigation Menu

Confined or spread disease-Spread with distant metastasis Posts on Medivizor

Metastasis surgery improves survival of patients with advanced colorectal cancer

Posted by on Jan 21, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the survival outcomes of patients who underwent surgery for colorectal cancer (CRC) metastasis (spread to other parts of the body). Researchers suggested that metastasis surgery is associated with survival improvement in these patients. Some background CRC is one of the most common cancers worldwide. A...

Read More

Robotic versus laparoscopic liver surgery is a safe treatment for metastatic colorectal cancer

Posted by on Dec 17, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of robotic-assisted liver surgery (RALS) compared to laparoscopic liver surgery (LLS) in advanced colorectal cancer. Researchers suggested that RALS is similarly safe and effective as LLS for these patients. Some background Colorectal cancer is one of the most common cancers worldwide....

Read More

High neutrophil-to-lymphocyte ratio in patients with melanoma treated with PD-1 inhibitor

Posted by on Dec 9, 2019 in Melanoma | 0 comments

In a nutshell This study wanted to find out if a high neutrophil-to-lymphocyte ratio (NLR) was related to the survival of patients with melanoma treated with PD-1 inhibitor treatment. The study found that the higher the NLR, the lower the chances of survival in these patients.  Some background One type of melanoma treatment involves...

Read More

Palbociclib and exemestane versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer

Posted by on Dec 7, 2019 in Breast cancer | 0 comments

In a nutshell This study aimed to compare the safety and effectiveness of palbociclib and endocrine therapy to capecitabine chemotherapy in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer.  This study concluded that palbociclib and endocrine therapy is more effective than...

Read More

Looking for patients with advanced triple negative breast cancer to test an experimental drug with three functions

Posted by on Oct 31, 2019 in Breast cancer | 0 comments

In a nutshell This trial is examining the safety and effectiveness of experimental drug mRNA-2752 in patients with advanced triple-negative breast cancer. The main outcome of the trial will be the number of side effects experienced by patients and response to treatment. This trial is recruiting in the United States and Israel. The details...

Read More

Encorafenib, cetuximab and binimetinib combined treatment improves survival of patients with advanced colorectal cancer

Posted by on Oct 31, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated whether treatment with encorafenib (Braftovi), binimetinib (Mektovi), and cetuximab (Erbitux) combined would increase survival in advanced colorectal cancer (CRC). Researchers suggested that this combined therapy increases the survival of patients with metastatic (spread to other parts of the...

Read More

Comparing endocrine treatment versus chemotherapy for metastatic breast cancer

Posted by on Oct 22, 2019 in Breast cancer | 0 comments

In a nutshell This study compared hormone therapy and chemotherapy for the treatment of metastatic (cancer that has spread) breast cancer. The authors concluded that hormone therapy plus targeted therapy is better than chemotherapy for patients with metastatic breast cancer. Some background Different types of breast cancer have different receptors....

Read More

Looking for patients with hormone-receptor positive metastatic breast cancer to test an experimental biological drug

Posted by on Sep 30, 2019 in Breast cancer | 0 comments

In a nutshell This study is examining the effectiveness of biological drug sacituzumab govitecan (IMMU-132) compared to standard treatments for patients with hormone receptor-positive metastatic breast cancer. The main outcomes that will be measured are cancer responsiveness to the drug and survival of patients without the cancer growing. This trial...

Read More

Looking for participants with advanced colorectal cancer to test a combination therapy

Posted by on Sep 25, 2019 in Colorectal cancer | 0 comments

In a nutshell This phase 1/2 trial is examining the effectiveness of standard therapy alone or combined with new drugs as first line treatment for advanced colorectal cancer. The main outcome to be measured will be safety and tumor response to the treatment.  The details Colorectal cancer is one of the most common cancers worldwide. A significant...

Read More

Treatment dose optimisation in patients with advanced colorectal cancer treated with regorafenib

Posted by on Sep 25, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety of increasing doses of regorafenib (Stivarga) doses in patients with advanced colorectal cancer. Researchers suggested that this method with increasing doses should be used to assess the optimal dose for each patient. Some background Colorectal cancer is the third most common cancer...

Read More